Get access

Follicular Dynamic and Immunoreactions of the Vitrified Ovarian Graft After Host Treatment with Variable Regimens of Melatonin

Authors

  • Masoud Hemadi,

    1. Cellular and Molecular Research Center (CMRC), Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
    2. Fertility and Infertility Research Center, Imam Khomeini Hospital, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
    Search for more papers by this author
  • Saeed Shokri,

    1. Anatomy Department, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
    Search for more papers by this author
  • Elham Pourmatroud,

    1. Fertility and Infertility Research Center, Imam Khomeini Hospital, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
    Search for more papers by this author
  • Farideh Moramezi,

    1. Fertility and Infertility Research Center, Imam Khomeini Hospital, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
    Search for more papers by this author
  • Ali Khodadai

    1. Department of Immunology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
    Search for more papers by this author

Masoud Hemadi, Fertility and Infertility Research Center, Imam Khomeini Hospital, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Golestan Avenue P.O. Box 61355-189, Ahvaz, Iran.
E-mail: mhemadi@razi.tums.ac.ir

Abstract

Citation
Hemadi M, Shokri S, Pourmatroud E, Moramezi F, Khodadai A. Follicular dynamic and immunoreactions of the vitrified ovarian graft after host treatment with variable regimens of melatonin. Am J Reprod Immunol 2012; 67: 401–412

Problem  This study investigates dose-dependent effects of melatonin on ovarian graft.

Method of Study  Vitrified-thawed whole ovaries of newborn mice were grafted into ovariectomized mature ones. Melatonin (20, 50, 100, and 200 mg/kg/day) was administrated to separate groups of host mice for 32 days. IgM and IgG antibodies, Th1 and Th2 cytokines, and melatonin in recipient’s blood were measured. Subsequent survival of the grafted ovaries was scored. An assessment of follicular morphology was performed using TUNEL assay and hematoxylin-eosin staining.

Results  The administration of melatonin did not disturb the circadian rhythm of melatonin concentration. The ovarian graft lifespan was prolonged at 200 mg/kg/day melatonin (< 0.001). However, in doses of higher than 20 mg/kg/day melatonin, the proportion of healthy follicles and ovary size decreased. Th1 cytokines levels were reduced dose dependently. However, the effect of melatonin on Th2 cytokines was not pronounced. IgM and IgG2a decreased in recipients receiving 200 mg/kg/day melatonin in comparison with non-treated group (< 0.001), while this variables were significantly increased at the dose of 50 mg/kg/day (< 0.001).

Conclusion  Melatonin at 200 mg/kg/day has an immunosuppresent effect and produce prolongation of graft survival. However, the associated reduction in healthy follicles suggests that melatonin in doses of higher than 20 mg/kg/day has no preventative ischemic action.

Ancillary